Truvada ruling could allow cheap HIV prevention in the UK

19 September 2018 - Cheap copies of Gilead’s HIV drug Truvada, which can also be used to reduce the risk ...

Read more →

My Health Record: big pharma can apply to access data

18 September 2018 - ‘Each application would be assessed on its own merits,’ senators told. ...

Read more →

Calls for life-saving drug to be free

19 September 2018 - A former heroin addict, whose brother died from a drug overdose, has called for a life-saving ...

Read more →

NICE rejects Novartis’ CAR-T Kymriah for adult lymphoma

19 September 2018 - The National Institute for Health and Care Excellence has turned down NHS funding for use of ...

Read more →

NICE encourages further discussions on Kymriah for adult lymphoma

19 September 2018 - CAR-T is too expensive to recommend as a treatment for adults with lymphoma, NICE says in draft ...

Read more →

Information forums - streamlining PBS medicines listing processes

18 September 2018 - The Department of Health in collaboration with Medicines Australia will be hosting information forums in both ...

Read more →

Changes to TGA/PBAC parallel processing arrangements for biosimilar medicines

18 September 2018 - Submissions requesting the listing of a new biosimilar medicine are no longer eligible to be submitted under ...

Read more →

Pharma companies avoid estimated $215m a year in local tax: Oxfam

18 September 2018 - Pharmaceutical companies behind some of Australia’s best-known brands avoided an estimated $215 million a year in ...

Read more →

Targeted treatment for melanoma to be free on NHS

17 Septembre 2018 - Hundreds of patients with a type of aggressive skin cancer will be offered a targeted therapy ...

Read more →

Patients with high-risk skin cancer have new treatment option

17 September 2018 - Hundreds of patients with a type of advanced skin cancer are set to benefit from a new ...

Read more →

UK ‘less interesting’ to pharma because of Brexit – Roche CEO

14 September 2018 - The UK could be “less interesting” to pharma and life sciences firms after Brexit, the CEO ...

Read more →

Blood cancer drugs added to PBS

14 September 2018 - The Federal Government is spending $48 million to provide more affordable drugs for Australians with blood ...

Read more →

PHARMAC defends position not to fund bowel cancer drug

14 September 2018 - PHARMAC is defending its position to not fund a drug recommended to patients with late-stage bowel cancer ...

Read more →

Dying cancer patients refused PHARMAC funding

13 September 2018 - Dying patients who suffer a rare reaction to chemotherapy are having to pay for their own ...

Read more →

DoH moves to ensure equal access to cancer drugs in Northern Ireland

13 September 2018 - The Department of Health in Northern Ireland has unveiled plans to boost access to innovative new ...

Read more →